Dr. Yang was a research scholar at the Alzheimer’s Disease Research Center Washington University in St Louis USA. Currently, he serves as the Director of Neurology, Kaohsiung Municipal Ta-Tung Hospital.
He was elected as the executive director of Taiwan Dementia Society and Director of Taiwan Alzheimer’s Disease Association, and was awarded The First Place of Research Award, Taiwan Dementia Society in 2010. He was nominated and awarded in Marquis Who’s Who in The World, 2014&2015, and has published more than 100 manuscripts in dementia-related field, and has been awarded as The Innovation and Impaction Papers: 2013 World Biomedical Frontiers. He has initiated the Asian Society Against Dementia collaborated studies including AD8 (AD8-Asia) to screen early dementia in Asian countries and the registration of Alzheimer’s disease in Asian Countries (ReAD-Asia) to foster collaboration. He has also conducted pharmacogenomics, clinical trials, and basic molecular biological studies, gene expression and protein analyses in AD and serves as the Editor of Frontier of Bioscience, Associate Editor of Journal of Alzheimer’s Disease and Lead Editor of Scientific World Journal. Apart from these Journals, he also serves as Editor board member of Journal of Neurology, Caspian Journal of neurological Sciences, and Collegium Antropologicum.
Why are you excited about participating in APSC 2017?
Asian area will be the greatest population of people and demented persons in the world. Working with and collaborating to these countries brought by APSC would be a important issue to overcome the disease and foster the establishment of research bases for coming studies.